CoChat

Multiple Independent Emergences of Type 2 Vaccine-Derived Polioviruses during a Large Outbreak in Northern Nigeria

Open access

The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.

Abstract

Since 2005, a large poliomyelitis outbreak associated with type 2 circulating vaccine-derived poliovirus (cVDPV2) has occurred in northern Nigeria, where immunization coverage with trivalent oral poliovirus vaccine (tOPV) has been low. Phylogenetic analysis of P1/capsid region sequences of isolates from each of the 403 cases reported in 2005 to 2011 resolved the outbreak into 23 independent type 2 vaccine-derived poliovirus (VDPV2) emergences, at least 7 of which established circulating lineage groups. Virus from one emergence (lineage group 2005-8; 361 isolates) was estimated to have circulated for over 6 years. The population of the major cVDPV2 lineage group expanded rapidly in early 2009, fell sharply after two tOPV rounds in mid-2009, and gradually expanded again through 2011. The two major determinants of attenuation of the Sabin 2 oral poliovirus vaccine strain (A 481 in the 5′-untranslated region [5′-UTR] and VP1-Ile 143 ) had been replaced in all VDPV2 isolates; most A 481 5′-UTR replacements occurred by recombination with other enteroviruses. cVDPV2 isolates representing different lineage groups had biological properties indistinguishable from those of wild polioviruses, including efficient growth in neuron-derived HEK293 cells, the capacity to cause paralytic disease in both humans and PVR-Tg21 transgenic mice, loss of the temperature-sensitive phenotype, and the capacity for sustained person-to-person transmission. We estimate from the poliomyelitis case count and the paralytic case-to-infection ratio for type 2 wild poliovirus infections that ∼700,000 cVDPV2 infections have occurred during the outbreak. The detection of multiple concurrent cVDPV2 outbreaks in northern Nigeria highlights the risks of cVDPV emergence accompanying tOPV use at low rates of coverage in developing countries.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jvi.02954-12

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 102 references

Research works printed but not linked: 5

  1. 10.1001/jama.1987.03390100073029 · doi:10.1001/jama.1987.03390100073029 · Paper page
  2. World Health Organization. 2004. Polio laboratory manual, 4th ed. World Health Organization, Geneva, Switzerland.
  3. 10.2307/3213548 · doi:10.2307/3213548 · Paper page
  4. SabinAB. 1959. Recent studies and field tests with a live attenuated poliovirus vaccine, p 14–33. In Live poliovirus vaccines: papers presented and discussions held at the First International Conference on Live Poliovirus Vaccines. Pan American Sanitary Bureau, Washington, DC.
  5. FoxJP LeBlancDR GelfandHM ClemmerDJ PotashL. 1960. Spread of a vaccine strain of poliovirus in southern Louisiana communities, p 144–155. In Second International Conference on Live Poliovirus Vaccines. Pan American Health Organization scientific publication no 60. Pan American Health Organization, Washington, DC.

Cited by

See all 153

Metadata

Authors
Burns, C. C., Shaw, J., Jorba, J., Bukbuk, D., Adu, F., Gumede, N., Pate, M. A., Abanida, E. A., Gasasira, A., Iber, J., Chen, Q., Vincent, A., Chenoweth, P., Henderson, E., Wannemuehler, K., Naeem, A., Umami, R. N., Nishimura, Y., Shimizu, H., Baba, M., Adeniji, A., Williams, A. J., Kilpatrick, D. R., Oberste, M. S., Wassilak, S. G., Tomori, O., Pallansch, M. A., & Kew, O.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • University of Maiduguri (NG)
  • University of Ibadan (NG)
  • National Institute for Communicable Diseases (ZA)
  • National Primary Health Care Development Agency (NG)
  • World Health Organization - Nigeria (NG)
  • National Institute of Infectious Diseases (JP)
  • University of Maiduguri Teaching Hospital, Maiduguri,
  • Department of Virology, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • Redeemer's University (NG)
Venue
Journal of Virology
Published
2013-05
Volume
87
Issue
9
Pages
4907-4922
ISSN
  • 0022-538X (ISSN-L)
  • 1098-5514
OpenAlex
W2031551277
Cited by
153
References
102
Citations by year
2026: 3 · 2025: 4 · 2024: 6 · 2023: 8 · 2022: 12 · 2021: 5 · 2020: 17 · 2019: 9 · 2018: 11 · 2017: 12 · 2016: 21 · 2015: 17 · 2014: 19 · 2013: 9
FWCI
14.97
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Journal of Virology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Bill and Melinda Gates Foundation
  • World Health Organization
  • Centers for Disease Control and Prevention
  • Japan Society for the Promotion of Science (25293111, 22390092)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
  • Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
Keywords
poliomyelitis outbreak, trivalent oral polio vaccine, vaccine attenuation, human-to-human transmission, Northern Nigeria
MeSH terms
Animals, Disease Outbreaks, Female, Humans, Male, Molecular Sequence Data, Nigeria, Phylogeny, Poliomyelitis, Poliovirus Vaccine, Oral, Poliovirus, Poliovirus Vaccines, Capsid Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multiple Independent Emergences of Type 2 Vaccine-Derived Polioviruses during a Large Outbreak in Northern Nigeria. https://app.cochat.ai/papers/10.1128/jvi.02954-12
The paper
Burns, C. C., Shaw, J., Jorba, J., Bukbuk, D., Adu, F., Gumede, N., Pate, M. A., Abanida, E. A., Gasasira, A., Iber, J., Chen, Q., Vincent, A., Chenoweth, P., Henderson, E., Wannemuehler, K., Naeem, A., Umami, R. N., Nishimura, Y., Shimizu, H., . . . Kew, O. (2013). Multiple Independent Emergences of Type 2 Vaccine-Derived Polioviruses during a Large Outbreak in Northern Nigeria. Journal of Virology. https://doi.org/10.1128/jvi.02954-12

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.